Deal tracker
Biopharma acquisitions, licensing deals and partnerships, updated automatically every day from company announcements and filings. Values are headline figures in US dollars, including milestone payments where disclosed.
- Deals in 2026
- 12
- Disclosed value
- $45bn
- Largest deal
- $19bn
| Announced | Buyer or partner | Target or asset | Type | Value | Status | Source |
|---|---|---|---|---|---|---|
| 16 Nov 2026 | Novartis | OBI PharmaNext-generation ADC platform | Licensing | $2bn$30mn upfront | Announced | Source โ |
| 30 Jan 2026 | AstraZeneca | CSPC Pharmaceutical GroupEight weight-management programmes | Licensing | $19bn$1.2bn upfront | Announced | Source โ |
